![Nicole Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole Jones
Investor Relations Kontakt på
ACHIEVE LIFE SCIENCES, INC.
Profil
Nicole Jones is currently VP-Strategic Communications & IR Contact at Achieve Life Sciences, Inc. since 2025.
Formerly, Ms. Jones worked as an Analyst at Flyover Capital Partners LLC.
Ms. Jones completed undergraduate and graduate degrees at the University of Kansas.
Aktiva positioner av Nicole Jones
| Företag | Position | Start |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Investor Relations Kontakt | 2025-08-01 |
Tidigare kända positioner av Nicole Jones
| Företag | Position | Slut |
|---|---|---|
Flyover Capital Partners LLC
 Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Private Equity-analytiker | - |
Nicole Joness utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flyover Capital Partners LLC
Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Finance |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
